Official Publications TME Pharma N.V.

Equities

Market Closed - Euronext Paris Other stock markets 11:21:58 2024-05-02 am EDT			5-day change	1st Jan Change
0.2435 ^EUR	-4.51%		-5.07%	+5.87%

Apr. 25	TME Pharma N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 23	TME Pharma N.V. Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two-Year Survival in GLORIA Phase 1/2 Trial in Brain Cancer	CI

Annual results	Apr. 24	CO
Admission of new securities	Dec. 13	CO
Admission of new securities	Dec. 13	CO
Half-year report	23-10-26	CO
1st-half-year results	23-10-26	CO
1st-half-year results	23-10-26	CO
Minutes of the general assembly	23-06-29	CO
Minutes of the general assembly	23-06-29	CO
Mixed general shareholder meeting	23-05-29	CO
Mixed general shareholder meeting	23-05-29	CO
Annual Report	23-04-23	CO
Annual results	23-04-17	CO
Annual results	23-04-17	CO
Minutes of the general assembly	23-01-29	CO
Minutes of the general assembly	23-01-29	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-01-02	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-01-02	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-01-01	CO
Changes in management and corporate officers	22-11-27	CO
Changes in management and corporate officers	22-11-27	CO
Half-year report	22-10-25	CO
1st-half-year results	22-10-25	CO
1st-half-year results	22-10-25	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	22-09-12	CO
Change of company name	22-07-14	CO